CA45562-5 - 0x000000000000649D

Males & Females of Non-Childbearing Potential

Mountain

* Stipend may pay up to reflected amount.
Start Date: 
February 20, 2025 - 2:30pm
End Date: 
March 7, 2025 - 12:00pm

Study Details

Study Number: CA45562
Group Number: 5
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,000.00

Study Criteria

Age: 19 - 55
BMI: 18 - 33
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease.
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type: Short Term
Study Length: 3 Night Stay & 1 Phone Call

Screening Dates:

Event Day Event Date
Thursday 2/13/2025
Friday 2/14/2025
Monday 2/17/2025
Tuesday 2/18/2025

Doctor Exam Dates:

Event Day Event Date
Thursday 2/13/2025
Friday 2/14/2025
Monday 2/17/2025
Tuesday 2/18/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Thursday 2/20/2025 2:30:00 PM Sunday 2/23/2025 9:15:00 AM 1 Lincoln
Phone participant Friday 3/7/2025 12:00:00 PM 1 Lincoln